CD83 and melanoma: Based on the aforementioned findings, melanoma cells could induce a transient immune response, increasing inflammatory cytokines levels, inducing CD83 and IDO1 expression in LCs, generating CD83+ LCs, either IDO1+/−, with correlation to primary melanoma MR rates.